T1	Disorder 62 81	lupus erythematosus
N1 	Reference T1 UMLS:C0409974	lupus erythematosus
T2	Disorder 317 336	lupus erythematosus
N2 	Reference T2 UMLS:C0409974	lupus erythematosus
T3	Pharmacological_substance 350 366	cyclophosphamide
N1000 	Reference T3 MeSH:D003520	cyclophosphamide
T4	Disorder 526 554	lupuslike autoimmune disease
T5	Pharmacological_substance 368 370	CY
N1001 	Reference T5 MeSH:D003520	CY
T6	Pharmacological_substance 620 622	CY
N1002 	Reference T6 MeSH:D003520	CY
T7	Pharmacological_substance 691 693	CY
N1003 	Reference T7 MeSH:D003520	CY
T8	Subject 510 517	animals
T9	Subject 294 304	adolescent
T11	Pharmacological_substance 140 147	placebo
N1004 	Reference T11 MeSH:D010919	placebo
T12	Pharmacological_substance 244 251	placebo
N1005 	Reference T12 MeSH:D010919	placebo
T14	Pharmacological_substance 28 35	adjunct
N1006 	Reference T14 MeSH:C069895	adjunct
N1007 	Reference T14 MeSH:C432482	adjunct
